Article
Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy
2025-07-11
Abstract excerpt
<h4>Summary</h4> Despite therapeutic advances, high-risk subtypes of B-cell acute lymphoblastic leukemia (B-ALL) such as Philadelphia chromosome-like (Ph-like) and KMT2A -rearranged ( KMT2A -R) remain a formidable clinical challenge. BRG1 (gene name SMARCA4 ), the ATPase subunit of the SWI/SNF chromatin-remodeling complex, has been extensively studied in solid tumors, where inactivating mutations are linked to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8aa569a-0599-52f6-92d9-3c59be254ba2
- DOI
- 10.1101/2025.07.08.661805
